MathiesenJS, KroustrupJP, VestergaardP, StochholmK, PoulsenPL, RasmussenAK, Feldt-RasmussenU, GaustadnesM, OrntoftTF, van Overeem HansenT, NielsenFC, BrixenK, GodballeC, FrederiksenAL. 2017. Distribution of RET mutations in multiple endocrine neoplasia 2 in Denmark 1994–2014: a nationwide study. Thyroid, 27:215–223.
2.
MargrafRL, CrockettDK, KrautscheidPM, SeamonsR, CalderonFR, WittwerCT, MaoR. 2009. Multiple endocrine neoplasia type 2 RET proto-oncogene database: repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlations. Human Mutat, 30:548–556.
3.
DemeesterR, ParmaJ, CochauxP, VassartG, AbramowiczMJ. 2001. A rare variant, I852M, of the RET proto-oncogene in a patient with medullary thyroid carcinoma at age 20 years. Human Mutat, 17:354.
4.
MachensA, SpitschakA, LorenzK, PutzerBM, DralleH. 2011. Germline RET sequence variation I852M and occult medullary thyroid cancer: harmless polymorphism or causative mutation?. Clin Endocrinol (Oxf), 75:801–805.
